Skip to main content

Boehringer Ingelheim Pty Limited

Regulatory activities for this sponsor.

Sponsor content

11 result(s) found, displaying 1 to 10
  • Australian Public Assessment Report for Nintedanib (as Esilate)
  • Australian Public Assessment Report for Tiotropium bromide
  • Australian Public Assessment Report for Afatinib (as dimaleate)
  • Australian Public Assessment Report for Linagliptin
  • Australian Public Assessment Report for Nevirapine
  • Australian Public Assessment Report for Telmisartan / Amlodipine
  • Australian Public Assessment Report for Alteplase

Help us improve the Therapeutic Goods Administration site